160 related articles for article (PubMed ID: 7710951)
21. Infrequent somatic mutations of the p16 and p15 genes in human bladder cancer: p16 mutations occur only in low-grade and superficial bladder cancers.
Miyamoto H; Kubota Y; Fujinami K; Dobashi Y; Kondo K; Yao M; Shuin T; Hosaka M
Oncol Res; 1995; 7(7-8):327-30. PubMed ID: 8747595
[TBL] [Abstract][Full Text] [Related]
22. Frequent mutations of the p53 gene and infrequent H- and K-ras mutations in urinary bladder carcinomas of NON/Shi mice treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
Yamamoto S; Masui T; Murai T; Mori S; Oohara T; Makino S; Fukushima S; Tatematsu M
Carcinogenesis; 1995 Oct; 16(10):2363-8. PubMed ID: 7586136
[TBL] [Abstract][Full Text] [Related]
23. Altered mRNA expression of the Rb and p16 tumor suppressor genes and of CDK4 in transitional cell carcinomas of the urinary bladder associated with tumor progression.
Quentin T; Henke C; Korabiowska M; Schlott T; Zimmerman B; Kunze E
Anticancer Res; 2004; 24(2B):1011-23. PubMed ID: 15161057
[TBL] [Abstract][Full Text] [Related]
24. Mutations in the p53 gene in schistosomal bladder cancer: a study of 92 tumours from Egyptian patients and a comparison between mutational spectra from schistosomal and non-schistosomal urothelial tumours.
Warren W; Biggs PJ; el-Baz M; Ghoneim MA; Stratton MR; Venitt S
Carcinogenesis; 1995 May; 16(5):1181-9. PubMed ID: 7767983
[TBL] [Abstract][Full Text] [Related]
25. Inactivation of the retinoblastoma susceptibility gene in non-small-cell lung cancer. The Lung Cancer Study Group.
Reissmann PT; Koga H; Takahashi R; Figlin RA; Holmes EC; Piantadosi S; Cordon-Cardo C; Slamon DJ
Oncogene; 1993 Jul; 8(7):1913-9. PubMed ID: 8390038
[TBL] [Abstract][Full Text] [Related]
26. Deletion mapping of chromosome 8 in cancers of the urinary bladder using restriction fragment length polymorphisms and microsatellite polymorphisms.
Knowles MA; Shaw ME; Proctor AJ
Oncogene; 1993 May; 8(5):1357-64. PubMed ID: 8097582
[TBL] [Abstract][Full Text] [Related]
27. Loss of heterozygosity of the retinoblastoma and p53 genes in primary cervical carcinomas with human papillomavirus infection.
Kim JW; Lee CG; Han SM; Kim KS; Kim JO; Lee JM; Kim IK; Namkoong SE
Gynecol Oncol; 1997 Nov; 67(2):215-21. PubMed ID: 9367711
[TBL] [Abstract][Full Text] [Related]
28. Abnormalities of retinoblastoma gene structure in human lung tumors.
Linardopoulos S; Gonos ES; Spandidos DA
Cancer Lett; 1993 Jul; 71(1-3):67-74. PubMed ID: 8103420
[TBL] [Abstract][Full Text] [Related]
29. Loss of heterozygosity and tumor suppressor gene mutations in chondrosarcomas.
Yamaguchi T; Toguchida J; Wadayama B; Kanoe H; Nakayama T; Ishizaki K; Ikenaga M; Kotoura Y; Sasaki MS
Anticancer Res; 1996; 16(4A):2009-15. PubMed ID: 8712735
[TBL] [Abstract][Full Text] [Related]
30. Loss of heterozygosity of the retinoblastoma gene is correlated with the altered pRb expression in human endometrial cancer.
Semczuk A; Marzec B; Roessner A; Jakowicki JA; Wojcierowski J; Schneider-Stock R
Virchows Arch; 2002 Dec; 441(6):577-83. PubMed ID: 12461615
[TBL] [Abstract][Full Text] [Related]
31. Diagnosis of bladder cancer by analysis of the allelic loss of the p53 gene in urine samples using blunt-end single-strand conformation polymorphism.
Sugano K; Tsutsumi M; Nakashima Y; Yamaguchi K; Ohkura H; Kakizoe T; Sekiya T
Int J Cancer; 1997 Aug; 74(4):403-6. PubMed ID: 9291429
[TBL] [Abstract][Full Text] [Related]
32. [Mutation and expression of Rb gene in human esophageal cancer].
Li HC
Zhonghua Zhong Liu Za Zhi; 1993 Nov; 15(6):412-4. PubMed ID: 8200276
[TBL] [Abstract][Full Text] [Related]
33. p53 Gene mutations in superficial bladder cancer.
Lorenzo Romero JG; Salinas Sánchez AS; Giménez Bachs JM; Sánchez Sánchez F; Escribano Martínez J; Hernández Millán IR; Segura Martín M; Virseda Rodríguez JA
Urol Int; 2004; 73(3):212-8. PubMed ID: 15539839
[TBL] [Abstract][Full Text] [Related]
34. [Diagnosis of a predisposition of retinoblastoma at the DNA level].
Murakami Y
Gan To Kagaku Ryoho; 1991 Jan; 18(1):44-50. PubMed ID: 1670986
[TBL] [Abstract][Full Text] [Related]
35. p53 mutations and prognosis in bladder tumors.
Uchida T; Wada C; Ishida H; Wang C; Egawa S; Yokoyama E; Kameya T; Koshiba K
J Urol; 1995 Apr; 153(4):1097-104. PubMed ID: 7869472
[TBL] [Abstract][Full Text] [Related]
36. p53 gene mutations in human urothelial carcinomas: analysis by immunohistochemistry and single-strand conformation polymorphism.
Oyasu R; Nan L; Szumel RC; Kawamata H; Hirohashi S
Mod Pathol; 1995 Feb; 8(2):170-6. PubMed ID: 7777479
[TBL] [Abstract][Full Text] [Related]
37. Alterations of Fas (APO-1/CD95) gene in transitional cell carcinomas of urinary bladder.
Lee SH; Shin MS; Park WS; Kim SY; Dong SM; Pi JH; Lee HK; Kim HS; Jang JJ; Kim CS; Kim SH; Lee JY; Yoo NJ
Cancer Res; 1999 Jul; 59(13):3068-72. PubMed ID: 10397246
[TBL] [Abstract][Full Text] [Related]
38. Loss of RB protein expression in primary bladder cancer correlates with loss of heterozygosity at the RB locus and tumor progression.
Xu HJ; Cairns P; Hu SX; Knowles MA; Benedict WF
Int J Cancer; 1993 Mar; 53(5):781-4. PubMed ID: 8449603
[TBL] [Abstract][Full Text] [Related]
39. Further characterization of retinoblastoma gene-mediated cell growth and tumor suppression in human cancer cells.
Zhou Y; Li J; Xu K; Hu SX; Benedict WF; Xu HJ
Proc Natl Acad Sci U S A; 1994 May; 91(10):4165-9. PubMed ID: 8183886
[TBL] [Abstract][Full Text] [Related]
40. Specific p53 gene mutations in urinary bladder epithelium after the Chernobyl accident.
Yamamoto S; Romanenko A; Wei M; Masuda C; Zaparin W; Vinnichenko W; Vozianov A; Lee CC; Morimura K; Wanibuchi H; Tada M; Fukushima S
Cancer Res; 1999 Aug; 59(15):3606-9. PubMed ID: 10446970
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
